nMP has been previously shown to be a developmental toxicant in rodents. this study reports current exposures to nMP in the spraying department of an automobile plant using biological monitoring. two specific metabolites, 5-hydroxy-N-methyl-2-pyrrolidone (5-hnMP) and 2-hydroxy-N-methyl-succinimide (2-hMSI), were analyzed in 69 urine samples of 14 workers exposed to nMP and 9 nonexposed controls. three different working tasks ('loading' and 'cleaning' of the sprayer system and 'wiping/packing' of the sprayed materials) and three sampling times (preshift, postshift, and preshift of the following day) were studied in exposed workers. Median exposures of 5-hnMP and 2-hMSI in postshift urine of exposed workers were 0.91 and 0.52 mg g −1 creatinine, respectively, whereas median levels in controls were below the limit of detection. decreased levels of 5-hnMP were observed in preshift urine samples on the following day (0.39 mg g −1 creatinine) in exposed workers, while the concentration of 2-hMSI did not change (0.49 mg g −1 creatinine). highest exposures occurred during sprayer cleaning with a maximum level of 8.31 mg g −1 creatinine of 5-hnMP in postshift urine. In contrast to 'wipers/packers', no decrease in 5-hnMP could be observed in preshift urine samples on day 2 of the 'loaders' and 'cleaners'. overall, exposure in terms of 5-hnMP postshift and 2-hMSI preshift of the following day were well below the current biological limit values of the European Union (70 and 20 mg g −1 creatinine). our results provide initial data on nMP exposure in the automobile industry and suggest that the analysis of 5-hnMP in preshift samples also provides essential information, particularly in situations involving direct handling of liquid nMP-containing formulations.
N-methyl-2-pyrrolidone (NMP) is miscible with both water and organic solvents, making it a powerful polar solvent for many industrial applications. Its primary use is as a solvent for varnishes, paints, and coating materials in the chemical and automobile industries. It is also used as an additive in the pharmaceutical and cosmetic industries, as well as in pesticide formulations. Additionally, NMP is used as a paint stripper, and a cleaning agent in the semiconductor industry. The overall annual world production capacity of NMP in 2003 was estimated at 100 000-150 000 tons (OECD, 2007) .
A major source of exposure to NMP at the workplace is via inhalation; however, NMP's ability to penetrate human skin suggests that dermal absorption is also a relevant route of exposure (Ursin et al., 1995; Anundi et al., 2000; Biomonitoring of exposure to N-methyl-2-pyrrolidone 767 et Keener et al., 2007) . For this reason, NMP and NMP-containing products and formulations have a skin notation (DFG, 2012) , and biological monitoring is considered the method of choice for exposure assessment at the workplace (Bader et al., 2008b) . Major metabolites in humans are 5-hydroxy-N-methyl-2-pyrrolidone (5-HNMP) and 2-hydroxy-N-methyl-succinimide (2-HMSI). Approximately 50-60% and 20-30% of the absorbed dose of NMP is excreted as 5-HNMP and 2-HMSI in urine, respectively (Wells et al., 1992; Åkesson and Jönsson, 1997) . The excretion half-lives in urine were determined to be approximately 6-8 h for 5-HNMP and 18-21 h for 2-HMSI (Carnerup et al., 2006; Bader et al., 2008b) .
Currently, the airborne occupational exposure limit value of the European Union for NMP is 40 mg m −3 (=10 ppm) at the workplace (SCOEL, 2007) . The corresponding biological limit value is 70 mg 5-HNMP per gram creatinine in postshift urine and 20 mg 2-HMSI per gram creatinine in preshift urine on the following day. In addition, NMP and formulations containing ≥5% NMP must be labeled as a reproductive toxicant and are categorized in group 1B (EC, 2009 ). The labeling is based on the observed developmental toxicity of NMP in animal experiments with the absence of maternal toxicity (Saillenfait et al., 2002 (Saillenfait et al., , 2003 . The median peak concentrations of 5-HNMP and 2-HMSI in urine after a developmentally toxic dose of 500 mg kg −1 day −1 in rats were reported to be 96 mmol l −1 (=11.05 g l ), respectively (Carnerup et al., 2005) . The corresponding urinary concentrations after a nondevelopmentally toxic dose of 125 mg kg ) and 3.5 mmol l −1 (=0.54 g l −1
). Here, we report current exposures to NMP in an automobile plant where NMP is applied as a solvent for varnishes and paints. For this purpose, a human biomonitoring approach was carried out for exposure assessment. Different workplaces were studied to identify working tasks with high exposures to NMP.
MEthodS

Study subjects and sample collection
Sixty spot urines were collected from 14 workers (12 men and 2 women; 8 smokers and 6 nonsmokers) to study exposure of NMP at the spraying department of an automobile plant. For each of the exposed workers, a spot urine sample was collected before and after the work shift, and preshift the next day, due to the known prolonged excretion half-life of 2-HMSI (n = 14 workers × 3 time points = 42 urine samples). A follow-up sampling was carried out 1 and 2 weeks later for three of the workers in the same spraying department. No technical changes or changes in protection measures were employed in the plant in the interim. Sampling was performed as described above (preshift, postshift, preshift next day) (n = 3 workers × 3 time points × 2 investigations = 18 samples). Nine employees (four men and five women; one smoker and eight nonsmokers) from the medical department of the same company served as controls (one urine sample each). Sampling for both workers and controls was carried out midweek and the samples were stored frozen at −20°C until analysis was carried out. Both exposed workers and controls worked a regular 8-h shift.
A questionnaire was filled out by all employees providing information on age, sex, body weight, smoking habits, workplace and working tasks, personal protective equipment at the workplace, and potential confounders outside the workplace, such as the use of paints and lacquers at home. All exposed workers were recruited from the spraying department where plastic inner section panels were sprayed using NMP-containing lacquers. For this purpose, the panels were loaded onto a conveyor chain and transported into a closed chamber where the actual spraying process was carried out. After drying the panels in an enclosed area within the spraying chamber, the panels were finally released back into the open workspace. There, the panels were wiped off, detached, and packed into boxes. The workers wore cotton gloves while handling the panels. There was no direct contact with NMP or NMP-containing solutions during these working tasks, and exposure of those workers was considered to be low ('wipers/packers', Fig. 1a,b) . In contrast, working tasks such as preparing the lacquers and directly loading the spraying system required the handling of liquid NMP-containing formulations. For this purpose, the workers were required to wear thin solvent-resistant gloves made out of laminate as personal protection measures. The gloves were used either alone or inside a second pair of gloves made out of polychloroprene or nitrile, which helped improve the grip. All gloves were discarded after a single use. Workers were also able to voluntarily use filter masks or as needed ('loaders', Fig. 1c,d ). The working tasks 'wiping/packing' and 'loading' were carried out on a daily basis and were considered to be representative of the work in the spraying department.
Special working tasks were also carried out in the spraying department at irregular intervals. These working tasks included disassembling and manually cleaning the nozzles, screws, nuts, and bolts of the sprayers because the sprayers can get clogged, thus influencing the quality of the spraying process and the spraying outcome. The cleaning process included the use of pure solvent mixtures containing up to 100% NMP. This process was suspected of causing short-term peak exposures to NMP. The employees again were required to wear solvent-resistant gloves (see loaders) and safety eyeglasses as personal protection measures ('cleaners', Fig. 1e,f) . In addition, workers were able to use filter masks on a voluntary basis and as they saw fit. An overview of the number of studied individuals and the number of urine samples is given in Fig. 2 .
Sample preparation and analysis
Samples were thawed directly before analysis and a 1 ml aliquot was taken for the determination of creatinine according to the Jaffé reaction (Larsen, 1972) . 5-HNMP and 2-HMSI were analyzed in urine based on a method previously published by Bader et al. (2008a) with modifications. 5-HNMP and 2-HMSI (analytical standards) and 5-HNMP-d 4 and 2-HMSI-d 3 (internal standards) are commercially available at Ramidus AB (Lund, Sweden). In brief, 600 µl urine was mixed with 400 µl of 1% acetic acid (HAc) and 200 µl of the internal standards (c = 10 mg l −1 ). The sample (2 × 500 µl) was transferred to a 1 ml ENV + SPE cartridge (100 mg). The latter was preconditioned with ethyl acetate/ethanol (EtOAc/EtOH) (4/1, v/v), methanol, and 1% HAc. Then, the cartridges were washed with 1% HAc and water and then dried. The metabolites were eluted with 1.75 ml EtOAc/EtOH (4:1, v/v). The eluate was evaporated to dryness and the residue was dissolved in acetonitrile and dried again to remove traces of water. The residue was reconstituted in 30 µl pyridine, and 30 µl N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide (MTBSTFA) was used for derivatization (110°C, 60 min). Finally, 50 µl EtOAc was added and 0.5 µl of the extract was analyzed by gas chromatography-mass spectrometry (GC-MS) in the single ion monitoring mode. For this purpose, a GC-MS system (Agilent 7890 GC, Agilent 5975 MS, CTC CombiPAL autosampler) equipped with a VF-WAX capillary column (30 m, 0.25-mm ID, 0.25 μm film thickness, Varian) was used. Helium 5.7 (1 ml min −1 ) was used as the carrier gas. The 0.5 µl extract was injected with a splitless technique at 240°C. The column temperature was 65°C for 0.5 min (initial temperature), Biomonitoring of exposure to N-methyl-2-pyrrolidone 769 raised to 90°C (25°C min −1 ; 1 min), and to a final temperature of 250°C (25°C min −1 ; 20 min). The transfer line temperature was set to 240°C. The temperature of the ion source was 230°C and the quadrupole was set to 150°C. Electron ionization was carried out at 70 eV. The electron multiplier was operated at 1200 V. The retention times were 8.48 min for 5-HNMP and 8.66 min for 2-HMSI. Characteristic ion fragments of 5-HNMP (m/z 172, 98), 2-HMSI (m/z 186, 144), and the internal standards 5-HNMP-d 4 (m/z 176, 102) and 2-HMSI-d 3 (m/z 189, 147) were monitored. The method provided a limit of detection (LOD) of 0.023 mg l −1 (23 µg l −1 ) for 5-HNMP and 0.015 mg l −1 (15 µg l −1 ) for 2-HMSI. The LOD was defined as a signal-to-noise ratio of 3. Spiked urine samples at concentrations close to the LOD were used to estimate the LOD according to the signal-to-noise ratio of 3 during method validation. The within-series and between-day imprecision (n = 7) at spiked concentrations of 0.8 mg l −1 was <10%.
Statistical analysis
Statistical analysis was carried out using Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). Descriptive analysis was carried out calculating mean, median, minimum, and maximum. Nonparametric data evaluation was used to study differences between exposed and nonexposed persons (Mann-Whitney) and differences between different time points of urine sampling such as pre-and postshift samples of workers (Wilcoxon). Differences were considered to be of statistical significance at P ≤ 0.05. When levels of 5-HNMP and 2-HMSI were below LOD, half of the LOD was used for statistical calculations.
rESUltS And dIScUSSIon
The aim of the study was to assess current exposures to NMP in the spraying department of the automobile industry. Since no changes in technical equipment, working tasks, or personal protection measures occurred between the initial visit and the visits 1 and 2 weeks later, all samples were evaluated together. All workers employed in the spraying department of the automobile plant were exposed to NMP (Table 1 , Supplementary data are available at Annals of Occupational Hygiene online). Median metabolite levels of exposed workers in postshift urine samples were 0.91 mg 5-HNMP per gram creatinine (mean 1.42 mg g −1 creatinine) and 0.52 mg 2-HMSI per gram creatinine (mean 0.64 mg g −1 creatinine). Three out of the 60 urine samples showed a creatinine content <0.3, while none was >3.0. Exclusion of these samples did not change the outcome. Overall, postshift exposures to NMP reported here were approximately 3-fold lower than those reported in other studies, e.g. during graffiti removal (Anundi et al., 2000) . There, mean exposures of 3.4 and 2.5 mg g −1 creatinine were found for 5-HNMP and 2-HMSI, respectively. Even higher exposures to NMP were observed at workplaces in an adhesive bonding compound and glue production facility (Bader et al., 2006) with mean exposures of approximately 28 mg g −1 creatinine (5-HNMP) and 3 mg g −1 creatinine (2-HMSI) in postshift urine samples of seven workers. The differences in exposures between all three studies can be explained by the specific exposure circumstances at the workplaces. The use of formulations containing 10-30% NMP was reported by Anundi and coworkers during graffiti removal, whereas Bader and coworkers even reported the use of formulations containing ~65% NMP in the glue production facility, e.g. during vessel cleaning. Both studies showed frequent dermal contact of the workers to these formulations. In contrast, the majority of the workers in the spraying department reported here belonged to the 'wipers/packers' (10 out of 14 workers) with no direct contact to liquid NMP or NMP-containing formulations.
A clear difference was observed in preshift urine samples of the first day between exposed workers and controls for 5-HNMP and 2-HMSI (P < 0.0001). The prevalence of positive results (>LOD) in preshift samples of exposed workers was 100% for both metabolites (median 5-HNMP: 0.34 mg g −1 creatinine; median 2-HMSI: 0.37 mg g −1 creatinine) owing to the fact that the samples were collected midweek. Therefore, exposures to NMP from the preceding work days cannot be ruled out. In contrast, 77% (6 out of 9) of the controls had levels of 5-HNMP and 2-HMSI below the LOD, thus resulting in a median level <LOD for both metabolites. Selected individual exposures of the controls were within the range of environmentally related background exposures to NMP (Schindler et al., 2012) and in line with low levels of NMP in the environment (Matsui et al., 1989; IPCS, 2001; OECD, 2007) . Thus, a major company-related contribution on background exposures of NMP can be ruled out for the controls although the medical department was directly located on the ground of the company.
Due to the well-known short excretion half-life of 5-HNMP (t 1/2 ~ 6-8) but prolonged elimination of 2-HMSI (t 1/2 ~ 18-21 h, Carnerup et al., 2006; Bader et al., 2007) , decreased levels of 5-HNMP were observed in preshift urine samples on the following day (~16 h postexposure) in exposed workers. Conversely, 2-HMSI concentrations either slightly increased or remained stable depending on creatinine adjustment. The expected differences between preshift samples on day 2 versus postshift samples on day 1 were observed, in particular for volume-related median concentrations of 5-HNMP (0.58 versus 0.91 mg l ). The kinetics was still apparent for 5-HNMP after adjusting for creatinine (0.39 versus 0.91 mg g −1 creatinine), whereas differences between preshift levels of the following day and postshift levels of the previous day could no longer be observed for 2-HMSI (0.49 versus 0.52, Fig. 3a,b) . The latter might be explained by the midweek sampling, thus leading to steady-state levels for long-term metabolites such as 2-HMSI.
The majority of the workers in the spraying department (10 out of 14 workers) reported here were 'wipers/packers'. In these workers, a 2.8-fold increase was observed for 5-HNMP in postshift urine samples (0.82 mg g −1 creatinine) compared to those before the shift (0.29 mg g −1 creatinine), while the levels of 2-HMSI in postshift urine (0.50 mg g −1 creatinine) were higher by a factor of 1.4 (0.35 mg g −1 creatinine). Although the spraying of the automobile parts is a closed process and these workers therefore had no direct contact to liquid NMP or NMP-containing formulations, the preshift levels of 5-HNMP and 2-HMSI in urine were approximately 30-40-fold higher than the corresponding median level of the controls (<LOD). These results may be explained by the fact that the panel coating is not always Table 1 . Volume-and creatinine-related concentrations of NMP metabolites in 69 spot urine samples of 9 nonexposed controls and 14 workers exposed to NMP in the spraying department of an automobile plant. completely dry when the panels are wiped off, thus leading to contamination of the cotton gloves followed by a potential dermal contact to NMP. In addition, exposure to NMP via inhalation cannot be completely excluded. The system-although considered to be a 'closed system'-requires moving the parts out of the sprayer chamber into the drying chamber and finally into the workspace of the 'wipers/packers', thus enabling short-term air flows between the spraying/drying system and the rest of the workplace.
The postshift median level of 5-HNMP derived from the 'loaders' was slightly higher (1.02 mg g −1 creatinine) compared to those of the 'wipers/ packers' (0.82 mg g −1 creatinine) reported above. A similar difference was observed for 2-HMSI (0.62 versus 0.50 mg g −1 creatinine). The differences, however, were not of statistical significance (P ≥ 0.3130) probably due to the low number of investigated loaders and the possible use of protective equipment, such as rubber gloves and breathing masks. In addition, 2-HMSI has a prolonged half-life and a lower rate of excretion in urine compared to 5-HNMP, thus further minimizing the differences between 'loaders' and 'wipers/packers' for 2-HMSI (P = 0.5592). Nevertheless, loaders are directly handling NMPcontaining varnishes to set up the spraying system, whereas no such exposures occur in 'wipers/ packers', thus explaining these small differences.
The highest exposures were observed for the two 'cleaners' directly handling NMP solutions-up to 100% NMP during sprayer cleaning. The preshift concentrations of 5-HNMP in the workers were 0.50 and 0.56 mg g −1 creatinine, thus being in line with the other workers at the company. After work, however, a 4-and 15-fold increase in exposure (2.16 and 8.31 mg g −1 creatinine) was observed. Nevertheless, these levels were still below the biological limit value of the European Union for 5-HNMP in postshift urine samples (70 mg g −1 creatinine; SCOEL, 2007). Slightly different results were observed for 2-HMSI. Pre-and postshift levels of 2-HMSI were almost identical in both workers (0.21 versus 0.24 mg g −1 creatinine and 1.08 versus 1.08 mg g −1 creatinine), while an approximately 10-and 5-fold increase, up to 2.64 and 4.83 mg g −1 creatinine, was observed in the preshift urine samples of the following day. Again, these levels were below the biological limit value of the European Union for 2-HMSI in preshift urine samples on the following day (20 mg g −1 creatinine; SCOEL, 2007) .
It is noteworthy to mention that no decrease in 5-HNMP could be observed in preshift urine samples of the cleaners and the loaders on the following day although this decrease should have occurred based on the short half-life of 5-HNMP (Fig. 4a) . In the particular case of the two 'cleaners', the levels of 5-HNMP even strongly increased in the preshift urine on the following day (11.77 and 12.50 mg g −1 creatinine). These results are possibly based on the fact that both 'cleaners' were using up to 100% NMP, whereas the 'loaders' were only handling aqueous NMP-containing formulations and varnishes. Multiple reasons for this stable or even increased excretion of 5-HNMP on the following day have been previously discussed, e.g. a delayed intracorporeal absorption and distribution after dermal absorption (Akrill et al., 2002) and varying penetration capabilities of aqueous NMP solutions through the skin (Keener et al., 2007). The delay due to dermal absorption was estimated to be approximately 4 h (Keener et al., 2007; Bader et al., 2008b) . Single working tasks with high exposures, such as filling or cleaning the spraying system, however, may be also carried out at the end of shift making the time of exposure an additional and independent contributing factor to higher preshift levels of 5-HNMP. The cross-common results derived from multiple studies on stable or even increased levels of 5-HNMP in preshift samples of the following day suggest that in situations with potential dermal contact to liquid NMP or liquid NMP-containing formulations, biomonitoring results from preshift urine samples using 5-HNMP can also provide essential information on NMP exposures. With the exception of a single sample pair, increased levels of 2-HMSI were observed on the following day for both 'cleaners' and 'loaders' (Fig. 4b ). This result was expected due to its longer half-life, thus confirming the suitability of 2-HMSI to assess repeated exposures of NMP in preshift samples (Jönsson and Åkesson, 2003) .
conclUSIonS
Our results show that workers in the spraying department of automobile plants can be exposed to NMP. Exposure was considerably lower compared to other industries and well below current biological limit values of the European Union for both 5-HNMP and 2-HMSI. 2-HMSI in preshift samples of the following day is supposed to be the critical parameter for exposure assessment due to its prolonged excretion half-life compared to 5-HNMP. However, the concentrations of 5-HNMP in preshift samples may also contribute to exposure assessment in case of handling liquid NMP or NMP-containing solutions, thus increasing the risk of dermal exposure or when the working tasks are carried out at the end of the shift. Therefore, urine samples should be preferably collected midweek or at the end of the working week and analyses restricted to preshift samples only. Such an approach-in combination with an analytical method capable of analyzing 5-HNMP and 2-HMSI in one analytical run-must be considered a step forward in both exposure and risk assessment.
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